Drug halves breast-cancer risk for vulnerable women

PARIS: Post-menopausal women with a family history of breast cancer more than halved the risk of developing the disease by taking an anti-hormone drug called anastrozole, researchers reported in The Lancet on Thursday.

Doctors at Queen Mary University in London found a reduction in risk of 53 percent among volunteers who took the drug for five years, compared to counterparts who took a harmless look alike called a placebo.